Nutrinia
Ramat Gan
About Nutrinia
Nutrinia is a neonatology company developing pharmaceuticals to treat rare conditions of the gastrointestinal tract. Our current products in development are oral formulations of insulin shown to enhance adaptation and rehabilitation of the gut in infants. We at Nutrinia live by the belief that science is best used to make life better for people, especially the most vulnerable populations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $43.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Aug 2016)
- Website: nutrinia.com
- Phone: 972-3-7262262
Industries & Categories
Biotechnology, Developer Tools, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/nutrinia-5108 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.